Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Neuro-Oncology
|
January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases
Stephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
JAMA Oncology
|
May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
David A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology Practice
|
February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Amanda L King, Kayla N Roche, Elizabeth Vera, et al.
Breast Cancer Research and Treatment
|
March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Nicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Journal of Neuro-Oncology
|
July 16, 2025
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases
Tia Cheunkarndee, Zsombor Ritter, Max Saint-Germain, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 8, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
Pei Jye Voon, Eric X Chen, Helen X Chen, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Neuro-Oncology
|
May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim, Michael Weller, Ahmed Idbaih, et al.
Breast Cancer Research and Treatment
|
October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
Matthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Neuro-Oncology
|
January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases
Stephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
JAMA Oncology
|
May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
David A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology Practice
|
February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Amanda L King, Kayla N Roche, Elizabeth Vera, et al.
Breast Cancer Research and Treatment
|
March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Nicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Journal of Neuro-Oncology
|
July 16, 2025
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases
Tia Cheunkarndee, Zsombor Ritter, Max Saint-Germain, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 8, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
Pei Jye Voon, Eric X Chen, Helen X Chen, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Neuro-Oncology
|
May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim, Michael Weller, Ahmed Idbaih, et al.
Breast Cancer Research and Treatment
|
October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
Matthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Page
of 9